We are live on ! Find out more
NMC

NEA Management Company Portfolio holdings

AUM $1.59B
1-Year Est. Return 234.06%
This Fund
S&P 500
This Quarter Est. Return
-11.19%
1 Year Est. Return
+234.06%
3 Year Est. Return
+822.97%
5 Year Est. Return
+865.41%
10 Year Est. Return
+12,585.11%
AUM
$2.41B
AUM Growth
-$441M
Cap. Flow
+$123M
Cap. Flow %
5.09%
Top 10 Hldgs %
73.82%
Holding
49
New
5
Increased
3
Reduced
1
Closed
6

Top Buys

Rank Stock Value
1
RYTM icon
Rhythm Pharmaceuticals
RYTM
+$130M
2
XFOR icon
X4 Pharmaceuticals
XFOR
+$28.1M
3
PHXM
PHAXIAM Therapeutics S.A.. American Depositary Shares
PHXM
+$14.8M
4
OBSV
ObsEva SA Ordinary Shares
OBSV
+$12.7M
5
KA
Kineta, Inc. Common Stock
KA
+$5.48M

Top Sells

Rank Stock Value
1
CRCM
CARE.COM, INC.
CRCM
+$51.8M
2
SCMP
Sucampo Pharmaceuticals, Inc.
SCMP
+$14.8M
3
SENS icon
Senseonics Holdings Inc
SENS
+$7.05M
4
PXLW icon
Pixelworks
PXLW
+$1.69M
5
ROKA
Sorrento Tech, Inc. Common Stock
ROKA
+$652K

Sector Composition

Rank Sector Weight
1 Healthcare 98.23%
2 Technology 1.77%
3 Consumer Discretionary 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PHXM
26
DELISTED
PHAXIAM Therapeutics S.A.. American Depositary Shares
PHXM
$13.8M 0.57%
+62,500
New +$14.8M
ELGX
27
DELISTED
Endologix Inc
ELGX
$13.3M 0.55%
249,020
– –
RIGL icon
28
Rigel Pharmaceuticals
RIGL
$828M
$12.6M 0.52%
324,315
– –
RGLS
29
DELISTED
Regulus Therapeutics
RGLS
$11.4M 0.47%
91,583
– –
NITE
30
DELISTED
Nightstar Therapeutics plc American Depositary Shares
NITE
$9.37M 0.39%
714,285
– –
TCON
31
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$9.24M 0.38%
13,796
– –
TRIL
32
DELISTED
Trillium Therapeutics Inc.
TRIL
$9.06M 0.38%
1,250,000
+200,000
+19% +$1.66M
DZSI
33
DELISTED
DZS Inc. Common Stock
DZSI
$8.86M 0.37%
956,255
– –
TRVN
34
DELISTED
Trevena, Inc.
TRVN
$6.1M 0.25%
6,099
– –
CSBR icon
35
Champions Oncology
CSBR
$66.1M
$6.06M 0.25%
1,562,500
– –
AFMD
36
DELISTED
Affimed
AFMD
$5.06M 0.21%
388,889
– –
VIRX
37
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$4.79M 0.2%
37,094
– –
MDB icon
38
MongoDB
MDB
$30.1B
$4.45M 0.18%
+150,000
New +$4.39M
ARQL
39
DELISTED
Arqule Inc
ARQL
$4.16M 0.17%
2,520,316
– –
AQ
40
DELISTED
Aquantia Corp. Common Stock
AQ
$2.71M 0.11%
+239,587
New +$2.72M
ORKA
41
Oruka Therapeutics
ORKA
$6.19B
$1.97M 0.08%
6,760
– –
AKTX
42
Akari Therapeutics
AKTX
$21.4M
$1.96M 0.08%
565
– –
OREX
43
DELISTED
Orexigen Therapeutics, Inc.
OREX
$478K 0.02%
370,900
– –
AVTX icon
44
Avalo Therapeutics
AVTX
$882M
– –
-207
Closed -$506K
GYRE icon
45
Gyre Therapeutics
GYRE
$710M
– –
-5,799
Closed -$220K
PXLW icon
46
Pixelworks
PXLW
$41.5M
– –
-29,963
Closed -$1.69M
CRCM
47
DELISTED
CARE.COM, INC.
CRCM
– –
-3,260,989
Closed -$51.8M
SCMP
48
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
– –
-1,258,507
Closed -$14.8M
ROKA
49
DELISTED
Sorrento Tech, Inc. Common Stock
ROKA
– –
-893,471
Closed -$652K
1
2

Similar funds

ADL
Asset Dedication LLC San Francisco, California $1.59B AUM 26.56% 1-Year Est. Return
CCP
Cryder Capital Partners London, United Kingdom $1.59B AUM 0.23% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
SW
SVB Wealth Boston, Massachusetts $1.59B AUM 24.57% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
W
Wealthquest Cincinnati, Ohio $1.59B AUM 18.1% 1-Year Est. Return
PIS
PPSC Investment Service Tokyo, Japan $1.58B AUM 47.89% 1-Year Est. Return
FWP
Falcon Wealth Planning Ontario, California $1.58B AUM 20.99% 1-Year Est. Return

NEA Management Company's Q4 2017 Portfolio in Review

As of Q4 2017, NEA Management Company held 49 positions worth $2.41B, down 15% from $2.86B the previous quarter. Its ten largest holdings account for 74% of the portfolio.

NEA Management Company deployed $123M of net new capital in Q4 2017, opening 5 new positions and adding to 3 existing holdings. Its largest new stake was Rhythm Pharmaceuticals: 4,912,306 shares worth $143M.

By sector, the portfolio is most concentrated in Healthcare at 98% of assets, up from 97% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Senseonics Holdings Inc, an estimated $7.05M trimmed.

  • NEA Management Company's largest Q4 2017 buy was Rhythm Pharmaceuticals: 4,912,306 shares worth $143M.
  • NEA Management Company added most to ObsEva SA Ordinary Shares in Q4 2017, an estimated $12.7M increase.
  • NEA Management Company's biggest Q4 2017 reduction was Senseonics Holdings Inc, cutting an estimated $7.05M.
  • NEA Management Company fully exited CARE.COM, INC. in Q4 2017, selling an estimated $51.8M.
  • NEA Management Company's ten largest holdings make up 74% of its $2.41B portfolio in Q4 2017.
  • NEA Management Company opened 5 new positions and closed 6 in Q4 2017.
  • NEA Management Company's portfolio value fell 15% quarter-over-quarter to $2.41B.

Based on NEA Management Company's 13F filing for Q4 2017, filed 8 Feb 2018.